Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Telomerase activation is a common feature of advanced human cancers and facilitates the malignant transformation of cultured human cells and in mice. These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis. However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of ApcMin Terc-/- mice, progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenoma-early carcinoma transition, a transition recognized for marked chromosomal instability. Together, these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We monitored the anaphase bridge index (ABI), an in vivo biomarker of the degree of telomere dysfunction in dividing tissues that mirrors chromosomal fusion frequency, in successive mTerc -/ -generations (7, 30) (see Materials and Methods for definition of ABI).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“The GI crypts of lategeneration mTerc -/ -Ink4a / Arf + / + and -/ -mice exhibited equally high levels of apoptosis (Fig. 1 C ), comparable to that in late-generation mTerc -/ -tissues with intact p53 function (7, 30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“This finding differs from that of the mTerc Apc Min model, wherein telomere dysfunction promotes the initiation of intestinal carcinomas but inhibits their progression (30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“Crosses of telomerase-deficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is functional51–55.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [52]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“gif" NDATA ITEM> ]> Telomerase activation is a common feature of advanced human cancer”
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Epithelial cancers occur infrequently in laboratory mice, and when they do occur they rarely exhibit the aberrant cytogenetic profiles typical of human carcinomas, such as severe aneuploidy and complex nonreciprocal translocation”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“and facilitates the malignant transformation of cultured human cell”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Together, the presence of short telomeres in colorectal carcinom”
BackgroundTHE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,596
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · cited 1×
“In successive generations of Apc Min Terc −/− mic”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citation
Cited by
Items 101–200 of 521
Proinvasion Metastasis Drivers in Early-Stage Melanoma Are Oncogenes
Scott, K. L., Nogueira, C., Heffernan, T. P., van Doorn, R., Dhakal, S., Hanna, J. A., Min, C., Jaskelioff, M., Xiao, Y., Wu, C.-J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.025 · Cited by 141
“…increasing malignant potential, the identification of extensive genome rearrangements in early-stage cancers (driven in part by telomere crisis) (Rudolph et al., 2001; Chin et al., 2004) raises the possibility that some tumors may acquire genomic alterations with significant metastatic…”
Self-citationThe role of transgenic mouse models in carcinogen identification.
Pritchard, J. B., French, J. E., Davis, B. J., & Haseman, J. K. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5778 · Cited by 138
“A new generation of transgenic models is also currently being developed (Berns 2001), such as one incorporating a point mutation in k-Ras (Johnson et al. 2001), or models subject to premature aging or having telomere dysfunction (Artandi and DePinho 2000; Rudolph et al. 2001).”
BackgroundMethodTRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Biroccio, A., Cherfils‐Vicini, J., Augereau, A., Pinte, S., Bauwens, S., Ye, J., Simonet, T., Horard, B., Jamet, K., Cervera, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2774 · Cited by 149
Telomere dysfunction, genome instability and cancer
Cheung, A. (2008) · Frontiers in Bioscience · doi:10.2741/2825 · Cited by 139
“In sporadic human colorectal tumors, anaphase bridges (associated with, but not specific for, telomere dysfunction) sharply increase at the transitional stage from adenoma to early carcinomas, but decline at metastasis stage (135).”
BackgroundCancer and aging: the importance of telomeres in genome maintenance
Rodier, F., Kim, S.-H., Nijjar, T., Yaswen, P., & Campisi, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.012 · Cited by 132
“That is, as validated in mouse models, while telomere dysfunction can fuel the genomic instability that facilitates cancer progression, it must also be resolved in order for cancer cells to survive [122-124].”
BackgroundCancer spectrum and outcomes in the Mendelian short telomere syndromes
Schratz, K. E., Haley, L., Danoff, S. K., Blackford, A. L., DeZern, A. E., Gocke, C. D., Duffield, A. S., & Armanios, M. (2020) · Blood · doi:10.1182/blood.2019003264 · Cited by 132
Mouse models in oncogenesis and cancer therapy
Céspedes, M. V., Casanova, I., Parreño, M., & Mangues, R. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0177-7 · Cited by 146
Plentz, R. R., Caselitz, M., Bleck, J. S., Gebel, M., Flemming, P., Kubicka, S., Manns, M. P., & Rudolph, L. K. (2004) · Hepatology · doi:10.1002/hep.20271 · Cited by 130
Self-citationMolecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
“Mice deficient in the telomerase RNA component over several generations gradually lose telomeres (Blasco et al., 1997), and become resistant to neoplasia (Greenberg et al., 1999; Gonzalez-Suarez et al., 2000; Rudolph et al., 2001).”
BackgroundChromosomal Instability in Tumor Initiation and Development
Bach, D., Zhang, W., & Sood, A. K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3235 · Cited by 140
“This role of telomeres has also been detected in cancer precursor lesions, for instance in colonic adenomas with high-grade dysplasia (54) and in ductal carcinoma in situ (55).”
The Role of Telomeres in Human Disease
Armanios, M. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-010422-091101 · Cited by 126
“In the first set, in several mouse models of cancer driven by both oncogene and tumor suppressor mutations, animals with short telomeres repeatedly showed an improved cancer-free survival, consistent with a potent tumor suppressive effect (37, 73, 79, 104).”
BackgroundEvolving views of telomerase and cancer
Blasco, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00085-0 · Cited by 123
Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01680-x · Cited by 118
The short and long telomere syndromes: paired paradigms for molecular medicine
Stanley, S. E., & Armanios, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.004 · Cited by 124
“The survival advantage occurs despite the fact that short telomere mice accumulate more microtumors because short telomeres provoke apoptosis and senescence [83,86].”
Genetic and epigenetic modulation of telomerase activity in development and disease
Liu, L., Lai, S. R., Andrews, L. G., & Tollefsbol, T. O. (2004) · Gene · doi:10.1016/j.gene.2004.06.011 · Cited by 137
O’Brien, S. L., Fagan, A., Fox, E., Millikan, R. C., Culhane, A. C., Brennan, D. J., McCann, A. H., Hegarty, S. M., Moyna, S., Duffy, M. J., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22413 · Cited by 120
“289(2) PR– 19 (56) 24 (48) 61 (38) 42 (45) PR1 15 (44) 26 (52) 101 (62) 51 (55) NHG 91 0.”
Farazi, P. A., Glickman, J., Horner, J., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Self-citationLo, A. W. I., Sprung, C. N., Fouladi, B., Pedram, M., Sabatier, L., Ricoul, M., Reynolds, G. E., & Murnane, J. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4836-4850.2002 · Cited by 118
“The results presented here and by others (3, 66) also demonstrate that nonreciprocal translocations are a common event after telomere loss.”
ResultVariation at theTERTlocus and predisposition for cancer
Baird, D. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000147x · Cited by 129
Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis
Pinzaru, A. M., Hom, R. A., Beal, A., Phillips, A. F., Ni, E., Cardozo, T., Nair, N., Choi, J., Wuttke, D. S., Sfeir, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.008 · Cited by 114
“Additional evidence in support of this paradigm emerged from the analysis of telomere dynamics in human tumors (Chin et al., 2004; Gordon et al., 2003; Rudolph et al., 2001) and the detection of telomeric fusions in several types of cancers (Lin et al., 2010; Simpson et al., 2015).”
BackgroundImportant molecular genetic markers of colorectal cancer
Kudryavtseva, A. V., Lipatova, A. V., Zaretsky, A. R., Moskalev, A. A., Fedorova, M. S., Rasskazova, A. S., Shibukhova, G. A., Snezhkina, A. V., Kaprin, A. D., Alekseev, B. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9796 · Cited by 114
“The study with Terc-deficient (telomerase RNA component) mice demonstrated association between telomere shortening and generation of intestinal carcinomas and microadenomas [41].”
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Sansregret, L., Patterson, J. O., Dewhurst, S. M., López‐García, C., Koch, A., McGranahan, N., Chao, W. C. H., Barry, D. J., Rowan, A., Instrell, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0645 · Cited by 125
de Magalhães, J. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.006 · Cited by 121
“RNA component (TERC) from the germline, while not preventing cancer [98], appears to increase cancer resistance [ 99 ].”
BackgroundTelomeres in aging and disease: lessons from zebrafish
Carneiro, M. C., de Castro, I. P., & Ferreira, M. G. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025130 · Cited by 106
“…rates (Artandi et al., 2000; Blanco et al., 2007; Rudolph et al., 1999), lower cancer rates (sometimes with more initiation events) (Farazi et al., 2003; González-Suárez et al., 2000; Greenberg et al., 1999; Hu et al., 2012; Rudolph et al., 2001) or unaltered cancer rates (Argilla et al., 2004).”
Tanaka, H., Bergstrom, D. A., Yao, M.-C., & Tapscott, S. J. (2005) · Nature Genetics · doi:10.1038/ng1515 · Cited by 104
Mammalian telomeres and telomerase: why they matter for cancer and aging
Blasco, M. A. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00335 · Cited by 122
Begus-Nahrmann, Y., Lechel, A., Obenauf, A. C., Nalapareddy, K., Peit, E., Hoffmann, E., Schlaudraff, F., Liss, B., Schirmacher, P., Kestler, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.426 · Cited by 88
“In addition, the number of anaphase bridges—which are hallmarks of telomere dysfunction and chromosomal fusio”
BackgroundSelf-citationEnd Resection Initiates Genomic Instability in the Absence of Telomerase
Hackett, J. A., & Greider, C. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8450-8461.2003 · Cited by 104
“Short telomeres can also limit tumor progression (24, 60).”
BackgroundExpression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma
Kondo, T., Oue, N., Yoshida, K., Mitani, Y., Naka, K., Nakayama, H., & Yasui, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1196 · Cited by 102
“was defined as reported previously (26).”
BackgroundChromosome instability in cancer: how, when, and why?
Gisselsson, D. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87164-6 · Cited by 120
Roger, L., Jones, R. E., Heppel, N. H., Williams, G. T., Sampson, J. R., & Baird, D. M. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt191 · Cited by 97
“In addition, anaphase bridging, used in this context as a surrogate marker of telomere dysfunction, has been reported at the adenoma/carcinoma transition (26).”
BackgroundTelomere instability and cancer
Londoño‐Vallejo, A. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.009 · Cited by 104
Telomeres and telomerase in cancer stem cells
Ju, Z., & Rudolph, K. L. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.040 · Cited by 100
Self-citationAnimal transgenesis: state of the art and applications
Melo, E. O., Canavessi, Á. M. O., Franco, M. M., & Rumpf, R. (2007) · Journal of Applied Genetics · doi:10.1007/bf03194657 · Cited by 114
“Many cancer cell lines showed alterations in the size and structure of their telomeres, and this fact can be related to the origin of some types of cancer ( Rudolph et al. 2001; Cawthon et al. 2003).”
BackgroundLetsolo, B. T., Rowson, J., & Baird, D. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1183 · Cited by 94
“Consistent with this, telomere length is reduced in some types of carcinoma compared to matched normal tissue (9–11) and an increase in anaphase-bridging, a surrogate marker of telomere fusion, is detected at the adenoma-carcinoma transition, a point that is characterized by increased chromosomal instability in colore…”
BackgroundGonzález-Suárez, E., Flores, J. M., & Blasco, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7291-7301.2002 · Cited by 95
“7) 0/8 (0) Adenocarcinoma 0/5 (0) 0/15 (0) 2/8 (25) Ovary Cyst 1/5 (20) 1/15 (6.”
BackgroundMethodInfluentialOh, B.-K., Kim, H., Park, Y. N., Yoo, J. E., Choi, J., Kim, K. S., Lee, J. J., & Park, C. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700710 · Cited by 105
“Anaphase bridging was defined as an anaphase event in which more than two-thirds of the distance between anaphase poles was spanned by the bridging chromosome”
BackgroundMany ways to telomere dysfunction: in vivo studies using mouse models
Goytisolo, F. A., & Blasco, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205085 · Cited by 105
“…reduce carcinogenesis as indicated by the study of intestinal carcinomas in Terc7/7 mice that also carry the Apcmin mutation (Su et al., 1992; Rudolph et al., 2001) or in mice de®cient for Terc and for the INK4A locus (a locus which includes two potent tumor suppressors p16 and p19ARF)…”
BackgroundSignaling through estrogen receptors modulates telomerase activity in human prostate cancer
Nanni, S., Narducci, M., Pietra, L. D., Moretti, F., Grasselli, A., Carli, P. D., Sacchi, A., Pontecorvi, A., & Farsetti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15552 · Cited by 101
DePinho, R. A., & Polyak, K. (2004) · Nature Genetics · doi:10.1038/ng0904-932 · Cited by 91
Self-citationBull, C., & Fenech, M. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108006988 · Cited by 91
Gisselsson, D., Jonson, T., Yu, C., Martins, C., Mandahl, N., Wiegant, J. C. A. G., Jin, Y., Mertens, F., & Jin, C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600438 · Cited by 103
“Investigations of colorectal polyps in mice have shown that BFB events may actually occur already at the dysplastic stage (Rudolph et al, 2001).”
BackgroundInactivation of hTERT transcription by Tax
Gabet, A., Mortreux, F., Charneau, P., Riou, P., Dodon, M. D., Wu, Y., Jeang, K., & Wattel, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206468 · Cited by 110
Telomere dysfunction in aging and cancer
Gilley, D. P., Tanaka, H., & Herbert, B. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.003 · Cited by 94
Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology
Pang, L. Y., & Argyle, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.010 · Cited by 105
“Studies in mTerc−/− mice showed that telomere shortening enhanced tumour initiation but suppressed tumour progression [80,84,85].”
BackgroundKamranvar, S. A., & Masucci, M. G. (2011) · Leukemia · doi:10.1038/leu.2011.35 · Cited by 97
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
Transcription factors and cancer: an overview
Nebert, D. W. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00269-x · Cited by 109
Telomere repeat binding factors: keeping the ends in check
Karlseder, J. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00706-1 · Cited by 88
“Furthermore, it was shown that these short telomeres confer resistance against skin tumorigenesis [2] and lead to a decline in the multiplicity and size of macroscopic adenomas [3].”
BackgroundPetsalaki, E., & Zachos, G. (2016) · Nature Communications · doi:10.1038/ncomms11451 · Cited by 95
Chromosome instability in cancer:how, when, and why?
Gisselsson, D. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87293-7 · Cited by 87
Telomerase abrogates aneuploidy‐induced telomere replication stress, senescence and cell depletion
Meena, J. K., Cerutti, A., Beichler, C., Morita, Y., Bruhn, C., Kumar, M., Kraus, J. M., Speicher, M. R., Wang, Z., Kestler, H. A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490070 · Cited by 87
“Anaphase bridges represent a hallmark feature of chromosomal fusions that form in response to: (i) telomere shortening (Rudolph et al , 2001), (ii) mutations in telomeric DNA (Kirk et al , 1997), (iii) the deletion of telomere-binding proteins (van Steensel et al , 1998), or (iv) telomere…”
Self-citationTelomeres: Implications for Cancer Development
Bernal, A., & Tusell, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010294 · Cited by 100
Toussaint, O., Dumont, P., Remacle, J., Dierick, J.-F., Pascal, T., Frippiat, C., Magalhaes, J. P., Zdanov, S., & Chainiaux, F. (2002) · The Scientific World JOURNAL · doi:10.1100/tsw.2002.100 · Cited by 86
“In agreement with this concept, the activation of p53 is the mediator of senescence induced by short telomeres[31,32].”
BackgroundGladdy, R. A., Taylor, M. D., Williams, C. J., Grandal, I., Karásková, J., Squire, J. A., Rutka, J. T., Guidos, C. J., & Danska, J. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00236-2 · Cited by 93
“Here, we show that RAG-1/2-induced DSB can cause IgH/ c-Myc translocations in p53 / Prkdc pro-B cells that become rearranged and amplified by BFB in vivo, generating complex chromosomal aberrations similar to those caused by telomere dysfunction (Artandi et al., 2000; Rudolph et al., 2001).”
BackgroundChromosome Fusions following Telomere Loss Are Mediated by Single-Strand Annealing
Wang, X., & Baumann, P. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.028 · Cited by 100
Frías-López, C., García-Aranda, C., de Juan, C., Morán, A., Ortega, P., Gómez, A., Hernándo, F., López-Asenjo, J. A., Torres, A.-J., Benito, M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.11.001 · Cited by 92
“[7] Rudolph KL, Millard M, Bosenberg MW, DePinho RA.”
BackgroundWhole chromosome loss is promoted by telomere dysfunction in primary cells
Pampalona, J., Soler, D., Genescà, A., & Tusell, L. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20749 · Cited by 95
“Evidence is accumulating that the loss of the telomere capping function due to proliferation-dependent telomere erosion is a crucial event in initiating cancer (Artandi et al., 2000; Rudolph et al., 2001; Lo et al., 2002; O’Hagan et al., 2002; Londoño-Vallejo, 2008).”
BackgroundChromosomal instability by β-catenin/TCF transcription in APC or β-catenin mutant cells
Aoki, K., Aoki, M., Sugai, M., Harada, N., Miyoshi, H., Tsukamoto, T., Mizoshita, T., Tatematsu, M., Seno, H., Chiba, T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210141 · Cited by 82
“In later stages, chromosomal aberrations and LOH are more frequently observed, and ABI is increased (Rudolph et al., 2001).”
BackgroundMethodMouse models of gastrointestinal tumors
Taketo, M. M. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00190.x · Cited by 81
Technologically advanced cancer modeling in mice
Tuveson, D. A., & Jacks, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00272-6 · Cited by 86
Maser, R. S., Wong, K.-K., Sahin, E., Xia, H., Naylor, M., Hedberg, H. M., Artandi, S. E., & DePinho, R. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01354-06 · Cited by 80
“of the degree of telomere dysfunction as defined previously (77), were deter-”
BackgroundSelf-citationTelomere length assessment in tissue sections by quantitative FISH: Image analysis algorithms
O'Sullivan, J. N., Finley, J. C., Risques, R.-A., Shen, W., Gollahon, K. A., Moskovitz, A. H., Gryaznov, S. M., Harley, C. B., & Rabinovitch, P. S. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20006 · Cited by 88
“Neoplastic and pre-neoplastic cells can harbor telomeric associations and anaphase bridges (7,8), providing evidence that telomere erosion promotes chromosomal instability (9–11).”
BackgroundMimeault, M., & Batra, S. K. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.12.001 · Cited by 85
Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells
Luo, L., Werner, K. M., Gollin, S. M., & Saunders, W. S. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.031 · Cited by 88
“Telomere dysfunction promotes CIN, including complex non-reciprocal translocation, regional amplication and deletions in p53-mutant mice [34,36] and an increase in initiated lesions in human colon carcinomas [35] that drive carcinogenesis.”
BackgroundBuilding ‘validated’ mouse models of human cancer
Hann, B. C., & Balmain, A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00283-0 · Cited by 91
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer
Nanni, S., Narducci, M., Pietra, L. D., Moretti, F., Grasselli, A., Carli, P. D., Sacchi, A., Pontecorvi, A., & Farsetti, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215552 · Cited by 81
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 96
“[44] Rudolph KL, Millard M, Bosenberg MW, DePinho RA.”
BackgroundMasutomi, K., & Hahn, W. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00703-6 · Cited by 83
“Strikingly, in human colon cancer specimens, anaphase bridges occur at a time when telomere shortening is likely, suggesting that a similar process occurs in human tumor pathogenesis [73].”
BackgroundInfluentialDietary Tricin Suppresses Inflammation-Related Colon Carcinogenesis in Male Crj: CD-1 Mice
Oyama, T., Yasui, Y., Sugie, S., Koketsu, M., Watanabe, K., & Tanaka, T. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0061 · Cited by 78
“In addition, we determined whether dietary tricin affects the chromosomal instability (41) of adenocarcinoma cells by counting the number of anaphase-bridging formations.”
BackgroundMethodInfluentialAttardi, L. D. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.04.019 · Cited by 87
O'Callaghan, N. J., Clifton, P. M., Noakes, M., & Fenech, M. (2009) · Rejuvenation Research · doi:10.1089/rej.2008.0819 · Cited by 71
Telomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions
Lantuéjoul, S., Soria, J., Morat, L., Lorimier, P., Moro‐Sibilot, D., Sabatier, L., Brambilla, C., & Brambilla, E. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1376 · Cited by 84
“(47), a progressive telomere shortening leads to cancer initiation by generating anaphase bridges, but telomerase reactivation is required secondarily for tumor progression.”
BackgroundFactors impacting human telomere homeostasis and age-related disease
Gilley, D. P., Herbert, B., Huda, N., Tanaka, H., & Reed, T. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.010 · Cited by 79
Plentz, R. R., Wiemann, S. U., Flemming, P., Meier, P. N., Kubicka, S., Kreipe, H., Manns, M. P., & Rudolph, K. L. (2003) · Gut · doi:10.1136/gut.52.9.1304 · Cited by 70
Self-citationTelomere Length Dynamics and the Evolution of Cancer Genome Architecture
Cleal, K., Norris, K., & Baird, D. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020482 · Cited by 81
“The promotion of large scale genome rearrangements and instability by telomere dysfunction 317 has been well documented [51, 114-118].”
BackgroundPhosphorylation of H2AX at Short Telomeres in T Cells and Fibroblasts
Hao, L.-Y., Strong, M. A., & Greider, C. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403924200 · Cited by 71
Mechanisms of chromosome-end protection
Cervantes, R. B., & Lundblad, V. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00325-3 · Cited by 80
Pampalona, J., Soler, D., Genescà, A., & Tusell, L. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.10.001 · Cited by 69
Role of telomere dysfunction in aging and its detection by biomarkers
von Figura, G., Hartmann, D., Song, Z., & Rudolph, K. L. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0509-5 · Cited by 76
“In contrast, tumor progression was impaired by induction of cell cycle arrest and apoptosis of tumor cells [15, 16 ].”
BackgroundSelf-citationQi, L., Strong, M. A., Karim, B. O., Armanios, M. Y., Huso, D. L., & Greider, C. W. (2003) · PubMed · Cited by 78
Chromosomal Instability in Barrett's Esophagus Is Related to Telomere Shortening
Finley, J. C., Reid, B. J., Odze, R. D., Sanchez, C. A., Galipeau, P. C., Li, X., Self, S. G., Gollahon, K. A., Blount, P. L., & Rabinovitch, P. S. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0837 · Cited by 82
“It has been suggested in ulcerative colitis (26), colon cancer (37), and mouse models (38) that telomere dysfunction promotes CIN through cycles of bridgebreakage-fusion.”
BackgroundResultTelomeres and chromosomal instability
Mathieu, N., Pirzio, L. M., Freulet-Marrière, M.-A., Desmaze, C., & Sabatier, L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3296-0 · Cited by 77
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres
Roake, C. M., & Artandi, S. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026088 · Cited by 67
“Interestingly, adenomas from these mice showed overexpression of p53 and an Cite this article as Cold Spring Harb Perspect Med 2017;7:a026088 7 w w w .p er sp ec ti ve si n m ed ic in e. o rg increased amount of apoptosis (Rudolph et al. 2001).”
BackgroundLeukocyte telomere length in a population-based case–control study of ovarian cancer: a pilot study
Mirabello, L., Garcia-Closas, M., Cawthon, R., Lissowska, J., Brinton, L. A., Pepłońska, B., Sherman, M. E., & Savage, S. A. (2010) · Cancer Causes & Control · doi:10.1007/s10552-009-9436-6 · Cited by 66
“progression of cancer [5-7].”
Cancer: the evolved consequence of a destabilized genome
Anderson, G. R., Stoler, D. L., & Brenner, B. M. (2001) · BioEssays · doi:10.1002/bies.1149 · Cited by 73
“Similarly, telomere dysfunction results in instabilities leading to increased numbers of microscopic stage tumors in the mouse colon, while reducing the incidence of later stage macroscopic tumors.((35)) Once an optimal degree of malignancy is reached, further genomic damage may not produce any selective advantage and…”
BackgroundGabet, A., Accardi, R., Bellopede, A., Popp, S., Boukamp, P., Sylla, B. S., Londoño‐Vallejo, A., & Tommasino, M. (2007) · The FASEB Journal · doi:10.1096/fj.07-8389com · Cited by 75
“Irrespective of the chromosome number, all metaphases are characterized by two stable translocations, t(1;5), t(9;10), emphasizing their clonal origin (Fig.”
BackgroundLechel, A., Holstege, H. H., Begus, Y., Schienke, A., Kamino, K., Lehmann, U., Kubicka, S., Schirmacher, P., Jonkers, J., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.045 · Cited by 75
Self-citationSchratz, K. E., Flasch, D. A., Atik, C. C., Cosner, Z. L., Blackford, A. L., Yang, W., Gable, D. L., Vellanki, P. J., Xiang, Z., Gaysinskaya, V. A., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.005 · Cited by 71
Wnt signaling and gastrointestinal tumorigenesis in mouse models
Taketo, M. M. (2006) · Oncogene · doi:10.1038/sj.onc.1210058 · Cited by 64
Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis
Widmann, T., Herrmann, M., Taha, N., König, J., & Pfreundschuh, M. G. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.009 · Cited by 66
Sperka, T., Song, Z., Morita, Y., Nalapareddy, K., Guachalla, L. M., Lechel, A., Begus‐Nahrmann, Y., Burkhalter, M. D., Mach, M., Schlaudraff, F., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2388 · Cited by 68
“Anaphase bridges represent a hallmark feature of this type of chromosomal instabilit”
BackgroundSelf-citationTelomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6
DeMaggio, A., Sundsvold, T., Wurscher, M. A., Koop, J. I., Klingelhutz, A. J., & McDougall, J. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207388 · Cited by 70
Else, T., Trovato, A., Kim, A. C., Wu, Y., Ferguson, D. O., Kuick, R. D., Lucas, P. C., & Hammer, G. D. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.011 · Cited by 62
“Later, the genome becomes stabilized through a telomere maintenance mechanism such as telomerase activity or alternative telomere length maintenance mechanisms (ALT) (Farazi et al., 2003; Maser and DePinho, 2002; Rudolph et al., 2001).”
BackgroundTelomere dysfunction and genome instability
Frias, C. (2012) · Frontiers in Bioscience · doi:10.2741/4044 · Cited by 61
Zhou, X. Z., Huang, P., Shi, R., Lee, T. H., Lu, G. H., Zhang, Z., Bronson, R. T., & Lu, K. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43452 · Cited by 64
“Notably, anaphase bridges, chromosome instability, and aneuploidy are very common in human cancers, especially epithelial tumors (63, 64).”
BackgroundTanaka, H., Cao, Y., Bergstrom, D. A., Kooperberg, C. L., Tapscott, S. J., & Yao, M.-C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01313-06 · Cited by 61
“An initial chromosome break followed by palindrome formation triggers BFB cycles, which further generate genetic diversity in premalignant and cancer cell populations (10, 28).”
BackgroundTelomere dysfunction and its role in haematological cancer
Jones, C. H., Pepper, C. J., & Baird, D. M. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09022.x · Cited by 66
Stadthagen, G., Tehler, D., Høyland-Kroghsbo, N. M., Wen, J., Krogh, A., Jensen, K. T., Santoni-Rugiu, E., Engelholm, L. H., & Lund, A. H. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003913 · Cited by 59
Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish
Lex, K., Maia-Gil, M., Lopes-Bastos, B., Figueira, M., Marzullo, M., Giannetti, K., Carvalho, T., & Ferreira, M. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920049117 · Cited by 62
“Correlating with telomere shortening across the several generations of telomerase-deficient mice, the authors observe increased tumor initiation but less growth and progression into advanced tumor stages (14).”
Background
Metadata
- Authors
- Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature Genetics
- Published
- 2001-06
- Volume
- 28
- Issue
- 2
- Pages
- 155-159
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1483245334
- Cited by
- 527
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 26 · 2012: 27
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- telomere dysfunction, telomerase activation, colorectal carcinogenesis, chromosomal instability, ApcMin/+ mice, TP53 mutation, anaphase bridges, tumor progression, tumor initiation, genome stability
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Cytoskeletal Proteins, Humans, Intestinal Neoplasms, Mice, Inbred C57BL, Mice, Mutant Strains, RNA, Colorectal Neoplasms, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Adenomatous Polyposis Coli Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.